1376 results about "Volatile solvents" patented technology

The invention relates to a substantially homogenous liquid composition capable of percutaneous delivery of one or more physiologically active agents, the composition including a rate modulating polymer, a volatile solvent and at least one physiologically active agent, said rate modulating polymer being selected to enable modulation of the rate of delivery of said physiologically active agent. Methods of percutaneous delivery of active agents and of prophylactic or therapeutic antimicrobial, antifungal or antiviral treatment using the compositions of the invention are also described.

Drugs, especially low aqueous solubility drugs, are provided in a porous matrix form, preferably microparticles, which enhances dissolution of the drug in aqueous media. The drug matrices preferably are made using a process that includes (i) dissolving a drug, preferably a drug having low aqueous solubility, in a volatile solvent to form a drug solution, (ii) combining at least one pore forming agent with the drug solution to form an emulsion, suspension, or second solution and hydrophilic or hydrophobic excipients that stabilize the drug and inhibit crystallization, and (iii) removing the volatile solvent and pore forming agent from the emulsion, suspension, or second solution to yield the porous matrix of drug. Hydrophobic or hydrophilic excipients may be selected to stabilize the drug in crystalline form by inhibiting crystal growth or to stabilize the drug in amorphous form by preventing crystallization. The pore forming agent can be either a volatile liquid that is immiscible with the drug solvent or a volatile solid-compound, preferably a volatile salt. In a preferred embodiment, spray drying is used to remove the solvents and the pore forming agent. The resulting porous matrix has a faster rate of dissolution following administration to a patient, as compared to non-porous matrix forms of the drug. In a preferred embodiment, microparticles of the porous drug matrix are reconstituted with an aqueous medium and administered parenterally, or processed using standard techniques into tablets or capsules for oral administration.

A nail lacquer effective for the treatment or prevention of fungal infections, such as, onychomycosis, includes fungicidally effective amount of ciclopirox, econazole, or other antifungal agent in a clear, stable, film-forming lacquer vehicle which includes a water-insoluble film-forming polymer; 2-n-nonyl-1,3-dioxolane or similar penetration enhancer; and volatile solvent. A plasticizer for the film-forming polymer which is also compatible with the other components may be included although the preferred penetration enhancers may also function as plasticizer. The composition, when applied to the nails provides a hard, clear, water-resistant film containing the antifungal agent. The film is resistant to multiple washings and is effective in the treatment of onychomycosis.

The present invention provides a pharmaceutical composition for transdermal delivery comprising: one or more physiologically active agents; one or more dermal penetration enhancers; a pharmaceutically acceptable carrier comprising a volatile solvent; and a hydrofluorocarbon propellent; wherein the carrier and penetration enhancers combine to provide a single-phase solution of the one or more physiologically active agents.

The present invention is drawn to adhesive formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can have a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least two non-volatile solvents. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.

A nail lacquer for the treatment or prevention of fungal infections, such as, onychomycosis, includes fungicidally effective amount of ciclopirox, econazole, or other antifungal agent in a compatible film-forming lacquer vehicle which includes a water-insoluble film-forming polymer; pentadecalactone, or similar cyclic lactone compound or derivative thereof, and volatile solvent. The pentadecalactone functions as a plasticizer for the film-forming polymer and as a penetration enhancer for the antifungal agent. The composition, when applied to the nails provides a hard, clear, water-resistant film containing the antifungal agent. The compositions are used for the treatment of onychomycosis.

The present invention relates to processes for preparing a stable suspension of carbon nanoparticles in a thermal transfer fluid to enhance thermal conductive properties, viscosity, and lubricity. One process is to disperse carbon nanoparticles directly into a thermal transfer fluid and other additives in the present of surfactants with intermittent ultrasonication. The second process is carried out in three stages. First, carbon nanoparticles are dispersed into a volatile solvent. Then, a thermal transfer fluid, surfactants, and other additives are added into this intermediate dispersion and mixed thoroughly. At last, the volatile solvent is removed to produce a uniformly dispersed nanofluid. The third process is to disperse carbon nanoparticles at an elevated temperature into a homogeneous mixture of surfactants and other additives in a thermal transfer fluid with help of a physical agitation. The present invention also relates to compositions of carbon nanoparticle nanofluids, such as nanolubricants and nanogreases. The nanofluid of the present invention is a dispersion of carbon nanoparticles, particularly carbon nanotubes, in a thermal transfer fluid in the present of surfactants. Addition of surfactants significantly increases the stability of nanoparticle dispersion. For nanogreases, carbon nanoparticles function both as a thickener to modulate viscosity and as a solid heat transfer medium to enhance thermal conductivity and high temperature resistance.

The present invention is drawn to solidifying formulations for dermal delivery of a drug for treating musculoskeletal pain, inflammation, joint pain, etc. The formulation can include a drug selected from certain drug classes, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system having one or more volatile solvent, and a non-volatile solvent system having one or more non-volatile solvent, wherein the evaporation of at least some of the volatile solvent converts the formulation on the skin into a solidified layer and the non-volatile solvent system is capable of facilitating the topical delivery of the drug(s) at therapeutically effective rates over a sustained period of time.

The invention relates to a wear-resisting super-hydrophobic coating composition as well as a preparation method and application thereof. The composition is prepared from a nano-material dispersion solution and a binding material dispersion solution. The nano-material dispersion solution is prepared by mixing a nanoparticle material, a hydrophobic silane coupling agent and a volatile solvent, wherein nanoparticles form a rough structure with a micro-nano dual scale through a mutual effect of the nanoparticles and the structure is dispersed in the solution of the hydrophobic silane coupling agent; the hydrophobic silane coupling agent has one or more groups and covalent bond connection is formed by the hydrophobic silane coupling agent and the micro-nano dual rough structure; meanwhile, thewear-resisting super-hydrophobic coating composition at least contains one hydrophobic group. A super-hydrophobic coating layer formed by the super-hydrophobic coating composition keeps a long-term effective super-hydrophobic property; the coating composition adopts a binding material so that the binding force between a super-hydrophobic structure and a matrix is enhanced and the protection effectof the coating layer is enhanced; a processing technology of the super-hydrophobic coating layer is simple and convenient and large-area construction is facilitated.

The present invention is drawn to sprayable formulations, methods of drug delivery, and resultant solidified layers for dermal delivery of a drug. The formulation can include a drug, a non-volatile solvent system, a solidifying agent, and a propellant. The formulation can have an initial viscosity suitable to be expelled out of a pressurized or manual pump container and applied onto a skin surface as a layer. When applied to the skin, the formulation can form a solidified layer after at least a portion of the propellant is evaporated.

Embodiments of the present invention overcome the well-known recalcitrance of lignocellulosic biomass in an economically viable manner. A process and a system are provided for the efficient fractionation of lignocellulosic biomass into cellulose, hemicellulose, and lignin. The cellulose and hemicellulose thus obtained are highly amorphous and can be readily converted into highly concentrated mixtures of five and six carbon sugars using known methods. Typical yields of sugars exceed 100 grams of sugars per liter of sugar solution. Other products, such as alcohols, can easily be prepared according to methods of the invention. The modest process conditions and low solvent/solid ratios of some embodiments of the invention require relatively low capital and processing costs.

A super hydrophobic self cleaning coating composition that can be applied by conventional methods such as by spraying the composition onto a surface creating a wet and dry dirt repellent coating on the surface. The super hydrophobic self cleaning coatings are used on exterior automotive and boat surfaces, and in many other applications, to produce a self cleaning surface, reduce adherence of dirt and contaminants to a treated surface, and reduce drag in some applications providing an energy savings. The coating utilizes a blend of organic and/or inorganic polymers with hydrophobic nanoparticles of fumed silica and/or titania in a volatile solvent which evaporates at ambient temperature. The coating solves the problem of poor resistance to UV light, opaque appearance, and/or some abrasion resistance not found in previous coatings of similar nature. A preferred coating has good resistance to UV light and some resistance to abrasion. Clear, nearly transparent and translucent coatings are produced as compared to conventional coatings of comparable hydrophobicity which are typically white or opaque. The coating can be applied by a single and easy spraying method and the super hydrophobic property can be achieved by drying the film by evaporation of the solvent at ambient temperature for 5 to 10 minutes. Embodiments of the super hydrophobic self-cleaning coating composition result in a clear coating or in some cases a translucent dirt repellant film for coating on painted material, plastic, metal, glass, ceramic, fiberglass or a polymer substrate. The coating utilizes a blend of organic and/or inorganic polymers with hydrophobic nanoparticles of fumed silica and/or titania in a volatile solvent. At least one preferred coating composition comprising an effective amount of a treated fumed silica in a solvent resulting in a coated surface providing a contact angle of at least 165 degrees as compared to water having a contact angle of from 10 to 15 degrees on a noncoated surface. The composition imparts a degree of hydrophobicity to a surface so that the surface will have a tilt angle of sliding of less than 2 degrees as compared to water on a noncoated surface having a tilt angle of sliding of 90 degrees or higher. The coating composition is removed by washing with a detergent or applying pressure to the coating wiping same from the treated surface. Exposure to water in the form of rain or snow does not remove the coating composition.

The present invention is drawn to adhesive solidifying formulations, methods of drug delivery, and solidified layers for dermal delivery of a drug. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system comprising at least one volatile solvent, and a non-volatile solvent system comprising at least one non-volatile solvent, wherein at least one non-volatile solvent is a flux-enabling non-volatile solvent(s) capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.

The present invention relates to a transparent wear-resistant super-hydrophobic coating material, a preparation method and a coating process thereof. The transparent wear-resistant super-hydrophobic coating material comprises a nanometer material dispersion liquid and an adhesion material dispersion liquid. According to the present invention, during the preparation, a nanometer material and a volatile solvent are mixed and dispersed to prepare the nanometer material dispersion liquid, and the adhesion material and the good solvent thereof are mixed and dispersed to prepare the adhesion material dispersion liquid; during the coating, the substrate surface is cleaned, the adhesion material dispersion liquid is coated to form the adhesion layer, the nanometer material dispersion liquid is coated after drying, the partial nanometer material is embedded into the adhesion layer through heating, pressurization and other ways, and finally the unstably-binding nanoparticles are removed by using scraping or adhesive tape adhesion to obtain the super-hydrophobic coating, wherein the coating has characteristics of good transparency, strong binding force, and wear resistance; and the super-hydrophobic coating material of the present invention can be used for the surfaces of a variety of materials such as metals, plastics, glass, cement boards and the like so as to achieve functions of water resistance, stain resistance, corrosion resistance, self-cleaning, dew resistance, icing resistance, and the like.

The present invention is drawn to adhesive formulations and methods of drug delivery. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least two volatile solvents, and a non-volatile solvent system including at least one non-volatile solvent, wherein at least one non-volatile solvent is capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.

The present invention is drawn to adhesive solidifying formulations for treating skin disorders, such as dermatitis or psoriasis. The formulation can include a drug, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent, wherein the non-volatile solvent system is capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.

A process for the extraction and purification of Paclitaxel from a natural source of taxanes, comprising extracting Paclitaxel with an organic solvent from a natural source of taxanes, and treating the raw material with a base or an acid to obtain a biomass by precipitation. The biomass is isolated and dried, and resin and natural pigments are removed. The biomass is then dissolved in acetone and at least one non-polar solvent is added, until a Paclitaxel-enriched oily phase is obtained. The Paclitaxel-enriched oily phase is then treated with a base or an acid to obtain a second biomass, which is recovered by precipitation and dried. A solution of the second biomass in a volatile solvent is chromatographically purified at least once and crystallized.

The invention provides a method for preparing drug sustained release nanofibers. The method is characterized by including the specific steps that (1) drug-carried micro-spheres are arranged in an organic solvent to be evenly stirred and vibrated to obtain core layer spinning solutions; (2) degradable solutes and volatile solvents are evenly mixed to prepare surface-layer spinning solutions; (3) the surface-layer spinning solutions and the core layer spinning solutions are injected into a surface-layer liquid storage tank and a core layer liquid storage tank of a coaxial spinning jet respectively, coaxial electrostatic spinning is carried out at the room temperature, and the volatile solvents in the surface-layer spinning solutions volatilize to form through holes in the spinning process to obtain the drug sustained release nanofibers with the porous surface layer and the drug-carried micro-sphere wrapped core layer. By means of the method, the obvious multi-stage drug release system is achieved, and the drug-carried micro-spheres are released in the core layer firstly to enter a hole channel in the surface layer and finally enter damaged target components of the nanofibers to give play to drug effects. The method is simple in operation and gentle in reaction condition. A drug sustained release curve is well controlled, and the drug using efficiency is improved.

The present invention is drawn to adhesive solidifying formulations for treating neuropathic pain. The formulation can include a drug suitable for treating neuropathic pain, a solvent vehicle, and a solidifying agent. The solvent vehicle can include a volatile solvent system including at least one volatile solvent, and a non-volatile solvent system including at least one non-volatile solvent capable of facilitating the delivery of the drug at therapeutically effective rates over a sustained period of time. The formulation can have a viscosity suitable for application to a skin surface prior to evaporation of the volatile solvents system. When applied to the skin, the formulation can form a solidified layer after at least a portion of the volatile solvent system is evaporated.

The invention relates to a drug delivery system for the topical administration of anesthetic agents. For example, a topical anesthetic for rapid local anesthesia is provided. The topical anesthetic includes an anesthetic, volatile and non-volatile solvents, and an optional thickener. In addition, a method is taught for applying the topical anesthetic to the face of a patient without occlusion. The anesthetic is applied topically to an area for injection such that the dermatological procedure (cosmetic injections) can be performed in fifteen minutes.